Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas.
BMC Cancer. 2019 Jun 10;19(1):556. doi: 10.1186/s12885-019-5743-9.
BMC Cancer. 2019.
PMID: 31182063
Free PMC article.
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options.
Ravegnini G, Fosso B, Ricci R, Gorini F, Turroni S, Serrano C, Pilco-Janeta DF, Zhang Q, Zanotti F, De Robertis M, Nannini M, Pantaleo MA, Hrelia P, Angelini S.
Ravegnini G, et al. Among authors: pilco janeta df.
Cancer Sci. 2022 Aug;113(8):2590-2599. doi: 10.1111/cas.15441. Epub 2022 Jun 21.
Cancer Sci. 2022.
PMID: 35633186
Free PMC article.
Item in Clipboard
Emerging drugs for the treatment of gastrointestinal stromal tumors.
Pilco-Janeta DF, García-Valverde A, Gomez-Peregrina D, Serrano C.
Pilco-Janeta DF, et al.
Expert Opin Emerg Drugs. 2021 Mar;26(1):53-62. doi: 10.1080/14728214.2021.1896704. Epub 2021 Mar 10.
Expert Opin Emerg Drugs. 2021.
PMID: 33645383
Review.
Item in Clipboard
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?
Gómez-Peregrina D, García-Valverde A, Pilco-Janeta D, Serrano C.
Gómez-Peregrina D, et al. Among authors: pilco janeta d.
Curr Treat Options Oncol. 2021 Feb 27;22(4):32. doi: 10.1007/s11864-021-00832-5.
Curr Treat Options Oncol. 2021.
PMID: 33641024
Review.
Item in Clipboard
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor.
García-Valverde A, Rosell J, Sayols S, Gómez-Peregrina D, Pilco-Janeta DF, Olivares-Rivas I, de Álava E, Maurel J, Rubió-Casadevall J, Esteve A, Gut M, Valverde C, Barretina J, Carles J, Demetri GD, Fletcher JA, Arribas J, Serrano C.
García-Valverde A, et al. Among authors: pilco janeta df.
Oncogene. 2021 Dec;40(48):6614-6626. doi: 10.1038/s41388-021-02049-0. Epub 2021 Oct 7.
Oncogene. 2021.
PMID: 34621020
Item in Clipboard
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.
Marino-Enriquez A, Novotny JP, Gulhan DC, Klooster I, Tran AV, Kasbo M, Lundberg MZ, Ou WB, Tao DL, Pilco-Janeta DF, Mao VY, Zenke FT, Leeper BA, Gokhale PC, Cowley GS, Baker LH, Ballman KV, Root DE, Albers J, Park PJ, George S, Fletcher JA.
Marino-Enriquez A, et al. Among authors: pilco janeta df.
Clin Cancer Res. 2023 Dec 15;29(24):5128-5139. doi: 10.1158/1078-0432.CCR-23-0998.
Clin Cancer Res. 2023.
PMID: 37773632
Item in Clipboard
Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors.
He W, Xu L, Ding J, Song L, Yang W, Klooster I, Pilco-Janeta DF, Serrano C, Fang H, Jiang G, Wang X, Yu J, Ou WB.
He W, et al. Among authors: pilco janeta df.
Biochim Biophys Acta Mol Basis Dis. 2023 Jun;1869(5):166690. doi: 10.1016/j.bbadis.2023.166690. Epub 2023 Mar 13.
Biochim Biophys Acta Mol Basis Dis. 2023.
PMID: 36921738
Item in Clipboard
Cite
Cite